Randomised, Clinical Controlled Study on Treatment of Intra-bony Defects With Enamel Matrix Protein (Emdogain®) vs. Nanocrystalline Hydroxyapatite (Ostim®)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00757159

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:13.611583+00:00

Published At

2012-01-18T00:00:00+00:00

Record Updated At

2012-01-18

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Periodontal Disease", "Periodontal Attachment Loss"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2012-01-18"

protocolSection.identificationModule.nctId

"NCT00757159"

protocolSection.identificationModule.officialTitle

"Randomised, Clinical Controlled Study on Treatment of Intra-bony Defects With Enamel Matrix Protein (Emdogain\u00ae) vs. Nanocrystalline Hydroxyapatite (Ostim\u00ae)"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Periodontal Disease (protocolSection.conditionsModule.conditions)
• Periodontal Attachment Loss (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.